BioSpace News Archive

4D Molecular Therapeutics announced that the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug Application (IND) for 4D-710 for the treatment of patients with cystic fibrosis.

Aerie Pharmaceuticals Announces Presentation at the 39th Annual Scientific Meeting of the American Society of Retina Specialists

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Radboud university medical center (Radboudumc), a leading Dutch academic research and teaching hospital (Nijmegen, the Netherlands), have announced the positive results of a clinical study conducted by Radboudumc aimed at setting a new standard of safety and accuracy in the diagnosis of small peripheral lung lesions.

Saniona today announced that it will present at multiple upcoming virtual investor conferences this fall. Details are as follows: Aktiespararna’s Aktiedagen Stockholm 2021 Date/Time: 11 October 2021, 19.00 CEST / 1:00 p.m. EDT

Elicio Therapeutics, today announced that the first patient has been dosed with ELI-002, an investigational lymph node-targeted therapeutic vaccine, by Shubham Pant, M.D. at MD Anderson as part of a Phase 1/2 (AMPLIFY-201) study evaluating its safety and efficacy as a treatment for patients with KRAS-driven tumors who have minimal residual tumor cells following surgery to remove the tumor.

Sunshine Biopharma Inc. today announced that it has filed a patent application for a potential new treatment for neurodegenerative disorders.

OncoResponse, a clinical-stage biotech company advancing immunotherapies derived from the immune systems of elite cancer responders, today announced that it will present three abstracts at the upcoming Society for Immunotherapy of Cancer’s (SITC) 36th Annual Meeting being held in Washington D.C.

Interventional urology is a branch of medicine that deals with the diagnosis and treatment of various urological and gynecological disorders with the use of minimally invasive surgical products.

Many patients who undergo dialysis often do not have a suitable vein from which impure blood can be removed.

The healthcare mobility solutions market is anticipated to witness a significant growth in the upcoming years on account of the increasing adoption of mobile clinical systems and accessibility of critical business.